Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1;43(2):96-105.
doi: 10.2500/aap.2022.43.210107.

Treatment strategies for postviral olfactory dysfunction: A systematic review

Affiliations

Treatment strategies for postviral olfactory dysfunction: A systematic review

Samuel N Helman et al. Allergy Asthma Proc. .

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has been associated with a dramatic increase in postviral olfactory dysfunction (PVOD) among patients who are infected. A contemporary evidence-based review of current treatment options for PVOD is both timely and relevant to improve patient care. Objective: This review seeks to impact patient care by qualitatively reviewing available evidence in support of medical and procedural treatment options for PVOD. Systematic evaluation of data quality and of the level of evidence was completed to generate current treatment recommendations. Methods: A systematic review was conducted to identify primary studies that evaluated treatment outcomes for PVOD. A number of medical literature data bases were queried from January 1998 to May 2020, with completion of subsequent reference searches of retrieved articles to identify all relevant studies. Validated tools for the assessment of bias among both interventional and observational studies were used to complete quality assessment. The summary level of evidence and associated outcomes were used to generate treatment recommendations. Results: Twenty-two publications were identified for qualitative review. Outcomes of alpha-lipoic acid, intranasal and systemic corticosteroids, minocycline, zinc sulfate, vitamin A, sodium citrate, caroverine, intranasal insulin, theophylline, and Gingko biloba are reported. In addition, outcomes of traditional Chinese acupuncture and olfactory training are reviewed. Conclusion: Several medical and procedural treatments may expedite the return of olfactory function after PVOD. Current evidence supports olfactory training as a first-line intervention. Additional study is required to define specific treatment recommendations and expected outcomes for PVOD in the setting of COVID-19.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
Figure 2.
Figure 2.
Treatment algorithm.

Similar articles

Cited by

References

    1. Yang J, Pinto JM. The epidemiology of olfactory disorders. Curr Otorhinolaryngol Rep. 2016; 4:130–141. - PMC - PubMed
    1. Hoffman HJ, Rawal S, Li CM, et al. . New chemosensory component in the US National Health and Nutrition Examination Surgery (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016; 17:221–240. - PMC - PubMed
    1. Tong JY, Wong A, Zhu D, et al. . The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020; 163:3–11. - PubMed
    1. Hannum ME, Ramirez VA, Lipson SJ, et al. . Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: a systematic review and meta-analysis. Chem Senses. 2020; 45:865–874. - PMC - PubMed
    1. Seiden AM. Postviral olfactory loss. Otolaryngol Clin North Am. 2004; 37:1159–1166. - PubMed

Publication types